BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31708932)

  • 1. Serum Clusterin and Complement Factor H May Be Biomarkers Differentiate Primary Sjögren's Syndrome With and Without Neuromyelitis Optica Spectrum Disorder.
    Qiao L; Deng C; Wang Q; Zhang W; Fei Y; Xu Y; Zhao Y; Li Y
    Front Immunol; 2019; 10():2527. PubMed ID: 31708932
    [No Abstract]   [Full Text] [Related]  

  • 2. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
    Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
    Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
    Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
    Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
    Kahlenberg JM
    Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
    Li X; Lu Z; Wang Y
    BMC Neurol; 2018 Oct; 18(1):168. PubMed ID: 30301458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
    Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
    Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
    Yoshimura S; Nakamura H; Horai Y; Nakajima H; Shiraishi H; Hayashi T; Takahashi T; Kawakami A
    Mod Rheumatol; 2016; 26(3):384-90. PubMed ID: 26375433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnancy-associated neuromyelitis optical spectrum disorder combined with primary Sjögren's syndrome: A critical illness case report].
    Wu J; Zhang W; Liang S; Qin YL; Fan WQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1118-1124. PubMed ID: 38101798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
    Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
    Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical characteristics of primary Sjögren syndrome with neuromyelitis optica].
    Qiao L; Luo Y; Zhang LL; Zhao LD; Wang Q; Xu Y; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):745-8. PubMed ID: 24314164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances.
    Akaishi T; Tarasawa K; Matsumoto Y; Sandhya P; Misu T; Fushimi K; Takahashi T; Fujimori J; Ishii T; Fujimori K; Yaegashi N; Nakashima I; Fujihara K; Aoki M
    J Neurol Sci; 2023 Sep; 452():120742. PubMed ID: 37515845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literature.
    Jayarangaiah A; Sehgal R; Epperla N
    BMC Neurol; 2014 Oct; 14():200. PubMed ID: 25291981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical blindness and not optic neuritis as a cause of vision loss in a Sjögren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD): Challenges of ascribing demyelinating syndromes to SS: a case report.
    Lalji A; Izbudak I; Birnbaum J
    Medicine (Baltimore); 2017 Aug; 96(34):e7454. PubMed ID: 28834867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis].
    Furukawa T; Matsui N; Tanaka K; Izumi Y; Kaji R
    Rinsho Shinkeigaku; 2017 Feb; 57(2):77-81. PubMed ID: 28132975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for serum specific biomarkers in patients with primary Sjögren's syndrome and interstitial lung disease using proteomic fingerprint techniques].
    Li YH; Sun XL; He J; Jia RL; Yang DY; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):240-3. PubMed ID: 22516996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Primary Sjögren's Syndrome Presenting as Mass-Like Encephalitis, With Progression to Neuromyelitis Optica Spectrum Disorder.
    Lee HJ; Chang SH; Kang EH; Lee YJ; Song YW; Ha YJ
    Arch Rheumatol; 2017 Dec; 32(4):353-357. PubMed ID: 29901009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary Sjögren's syndrome and neuromyelitis optica].
    Chourkani N; El Moutawakil B; Sibai M; Bourezgui M; Rafai MA; Slassi I
    Rev Med Interne; 2010 Sep; 31(9):e13-5. PubMed ID: 20554086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review.
    Torgashina AV; Vasilyev VI
    Ter Arkh; 2018 May; 90(5):76-80. PubMed ID: 30701893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.